ATP-Binding Cassette Transporter G8 Gene As a Determinant of Apolipoprotein B-100 Kinetics in Overweight Men

Objective—We examined the influence of genetic variation of the ATP-binding cassette (ABC) transporter G8 on apolipoprotein B (apoB) kinetics in overweight/obese men. Methods and Results—Very low–density lipoprotein (VLDL) and low-density lipoprotein (LDL) apoB kinetics were determined in 47 men (body mass index 32±3 kg/m2) using stable isotope and multicompartmental modeling to estimate production rate (PR), fractional catabolic rate (FCR), and VLDL to LDL–apoB conversion. Relative to the wild-type (400TT), subjects carrying the ABCG8 400K allele had significantly decreased plasma concentrations of triglycerides, sitosterol, and campesterol, lower PR of VLDL–apoB, and higher VLDL to LDL–apoB conversion (P<0.05). The PR and FCR of LDL–apoB were also significantly higher with 400K allele (P<0.05). No association was found with ABCG8 D19H. Compared with APOE2 or APOE3, APOE4 carriers had significantly higher plasma LDL-cholesterol concentrations and lower LDL–apoB FCR. During multiple regression analysis including age, homeostasis model assessment score, plasma concentrations of sitosterol, and lathosterol, ABCG8 and apoE genotypes were independent determinants of VLDL–apoB PR and LDL–apoB FCR, respectively (P<0.05). Conclusions—Variation in the ABC transporter G8 appears to independently influence the metabolism of apoB-containing lipoproteins in overweight/obese subjects. This may have therapeutic implications for the management of dyslipidemia in these subjects.

[1]  M. Laakso,et al.  Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M300522-JLR200 , 2004, Journal of Lipid Research.

[2]  J. Ordovás,et al.  ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin , 2004 .

[3]  M. Laakso,et al.  Polymorphisms in the ABCG 5 and ABCG 8 genes associate with cholesterol absorption and insulin sensitivity , 2004 .

[4]  H. Gylling,et al.  Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption DOI 10.1194/jlr.M200155-JLR200 , 2002, Journal of Lipid Research.

[5]  Jonathan C. Cohen,et al.  Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. , 2002, The Journal of clinical investigation.

[6]  G. Watts,et al.  Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. , 2002, Metabolism: clinical and experimental.

[7]  Jonathan C. Cohen,et al.  Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. , 2002, Journal of lipid research.

[8]  Jonathan C. Cohen,et al.  Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. , 2002, The Journal of clinical investigation.

[9]  Jonathan C. Cohen,et al.  Mutations in ATP‐cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia , 2001, Human mutation.

[10]  Anand K. Srivastava,et al.  Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption , 2001, Nature Genetics.

[11]  N. Grishin,et al.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. , 2000, Science.

[12]  A. Lichtenstein,et al.  Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Talmud,et al.  Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. , 2000, Journal of lipid research.

[14]  C. Mamotte,et al.  Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. , 1999, The American journal of physiology.

[15]  P. Talmud,et al.  Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men. , 1998, Journal of lipid research.

[16]  S. Sarna,et al.  Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study , 1998, BMJ.

[17]  G. Watts,et al.  Role of cholesterol in regulating apolipoprotein B secretion by the liver. , 1996, Journal of lipid research.

[18]  T. Mori,et al.  Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography-mass spectrometry with selective ion monitoring. , 1996, Redox report : communications in free radical research.

[19]  François Rousset,et al.  GENEPOP (version 1.2): population genetic software for exact tests and ecumenicism , 1995 .

[20]  H. Gylling,et al.  Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[21]  C. Packard,et al.  Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. , 1991, The Journal of clinical investigation.

[22]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[23]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[24]  R. Tilvis,et al.  Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. , 1990, American journal of epidemiology.